Back to ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC

All holdings · as of Dec 31, 2025

249 positions

CompanyClassValueShares% of portfolio
PROCAP ACQUISITION CORP$275.9K26,9400.0%
JD.com,Inc.JDADR$287.0K10,0000.0%
Surgery Partners, Inc.$309.0K20,0000.0%
JADE BIOSCIENCES, INC.$324.0K21,0000.0%
KIORA PHARMACEUTICALS, INC.$330.8K167,9410.0%
THERAPEUTICSMD INC$341.0K209,2100.0%
DAYFORCE, INC.$345.8K5,0000.0%
Aurinia Pharmaceuticals Inc.AUPHCommon Stock$350.9K22,0000.0%
BIOCRYST PHARMACEUTICALS INC$351.0K45,0000.0%
ORTHOPEDIATRICS CORPKIDSCommon Stock$352.4K19,8450.0%
Karyopharm Therapeutics Inc.$368.0K50,0000.0%
Keros Therapeutics, Inc.$383.8K18,8510.0%
Biohaven Ltd.$387.0K34,2770.0%
Vistagen Therapeutics, Inc.VTGNCommon Stock$412.7K623,5750.0%
Kura Oncology, Inc.$415.6K40,0000.0%
OMEROS CORP$429.4K25,0000.0%
Core Scientific, Inc./tx$436.8K30,0000.0%
NovoCure Ltd$439.6K34,0000.0%
Praxis Precision Medicines, Inc.$442.1K1,5000.0%
GERON CORP$443.8K336,1760.0%
POLYPID LTD$451.1K103,9500.0%
Elanco Animal Health Inc$452.6K20,0000.0%
Enliven Therapeutics, Inc.ELVNCommon Stock$462.0K30,0000.0%
BOSTON SCIENTIFIC CORP$476.8K5,0000.0%
Natera, Inc.$491.9K2,1470.0%
Apellis Pharmaceuticals, Inc.$502.4K20,0000.0%
WISDOMTREE TR$503.2K10,0000.0%
GLOBA TERRA ACQUISITION COR$514.0K50,0000.0%
Context Therapeutics Inc.$516.1K351,0940.0%
Cullinan Therapeutics, Inc.$517.5K50,0000.0%
MADRIGAL PHARMACEUTICALS, INC.$521.2K8950.0%
Alibaba Group Holding LtdBABAADR$524.5K3,5780.0%
Kyverna Therapeutics, Inc.KYTXCommon Stock$539.8K57,4280.0%
Intuitive Surgical Inc$577.7K1,0200.0%
Sarepta Therapeutics, Inc.$621.2K28,8660.0%
Tectonic Therapeutic, Inc.TECXCommon Stock$625.9K30,0070.0%
Neurogene Inc.NGNECommon Stock$631.0K30,6330.0%
Oruka Therapeutics, Inc.$631.7K20,8400.0%
ENANTA PHARMACEUTICALS INC$652.2K41,3570.0%
Gossamer Bio, Inc.$658.8K212,5310.0%
FORWARD AIR CORPFWRDCommon Stock$665.9K26,6350.0%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$671.6K19,7470.1%
Nuvalent, Inc.$688.2K6,8420.1%
ARVINAS, INC.$689.0K58,0910.1%
IDEAYA BIOSCIENCES, INC.$691.4K20,0000.1%
Larimar Therapeutics, Inc.$707.5K185,6890.1%
Phathom Pharmaceuticals, Inc.PHATCommon Stock$711.7K42,9000.1%
Guardant Health, Inc.$715.0K7,0000.1%
Ventyx Biosciences, Inc.$736.8K81,6000.1%
KEZAR LIFE SCIENCES INC$738.7K117,4400.1%
← PrevPage 2 of 5Next →